Holocene Advisors, LP Aclaris Therapeutics, Inc. Transaction History

Holocene Advisors, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $1.26 Million - $3.21 Million	-178,619 Reduced 10.74%	1,485,056 $12 Million
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $5.69 Million - $7.3 Million	-397,243 Reduced 19.28%	1,663,675 $26.2 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $22,402 - $41,216	2,300 Added 0.11%	2,060,918 $35.5 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $1.26 Million - $1.9 Million	103,013 Added 5.27%	2,058,618 $29.9 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $7.46 Million - $10.5 Million	557,233 Added 39.85%	1,955,605 $35.2 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $14.9 Million - $25.8 Million	872,509 Added 165.92%	1,398,372 $24.6 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $3.08 Million - $14.6 Million	525,863 New	525,863 $13.3 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.